Atlas Trials

Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer

Clinical trial NCT07076823 · RECRUITING

Trial details

NCT number
NCT07076823
Sponsor
West China Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal CancerSGLT-2 Inhibitor
Start date
2025-07-31
Primary completion
2026-06-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.